Press release
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Panic Attack Treatment Market
Panic Attack Treatment Market
Projected Market Size and Growth in the Panic Attack Treatment Market
The market for panic attack treatments is on a fast growth path, anticipated to reach $7.97 billion by 2030. This expansion reflects a compound annual growth rate (CAGR) of 17.3%. Several factors contribute to this anticipated rise, including the growing use of telehealth platforms, the increasing adoption of virtual reality and digital therapeutics, a rise in anxiety and panic disorder cases, progress in personalized medicine, and the broadening reach of online pharmacies alongside hospital distribution channels. Key trends shaping the market include the surge in telepsychiatry and mobile health apps, integration of virtual reality therapies specifically for panic disorders, wider application of neurofeedback and biofeedback techniques, development of personalized medication plans, and growth of mental health centers and hospital services.
Download a free report of the panic attack treatment market report:
https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Leading the Panic Attack Treatment Market
The panic attack treatment market features a number of prominent pharmaceutical and healthcare companies. Some of the leading players include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann?La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol?Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., and Cipla Limited.
Significant Acquisition Expands Neuroscience Portfolio
In August 2024, AbbVie Inc., a US-based biopharmaceutical giant, completed the acquisition of Cerevel Therapeutics for $8.7 billion. This strategic move was intended to bolster AbbVie's neuroscience portfolio by integrating Cerevel's promising pipeline of treatments targeting psychiatric and neurological disorders, particularly anxiety and panic-related conditions. Cerevel Therapeutics, also based in the US, is a clinical-stage biopharmaceutical company devoted to developing therapies that address neuroscience diseases including panic attacks.
View the full panic attack treatment market report:
https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Highlight Technological Advances in Treatment
Companies in the wearable ECG monitors space are increasingly developing AI-driven cardiac monitoring solutions that enhance diagnostic accuracy, patient comfort, and streamline clinical processes. These advanced systems utilize ultra-light, patch-based devices combined with deep learning algorithms to provide extended rhythm monitoring over several days, minimizing the need for traditional short-term Holter monitoring.
For example, in May 2025, iRhythm Technologies, a US digital healthcare firm specializing in wearable biosensors and cloud analytics, launched the Zio long-term continuous monitoring (LTCM) system. Marketed as the Zio ECG Recording and Analysis System, this device offers up to 14 days of continuous ECG monitoring via a thin, lightweight patch, achieving approximately 99% patient compliance and analyzable data. Its AI-powered algorithm, approved by the PMDA, detects 13 different arrhythmia types, with results reviewed by certified cardiographic technicians, ensuring 99% agreement with physician interpretations.
Core Segments of the Global Panic Attack Treatment Market
The report segments the global panic attack treatment market into several key categories:
1) Treatment Type: Cognitive Behavioral Therapy (CBT), Medications, Other Treatment Types
2) Drug Class: Antidepressants, Anti-Anxiety Drugs, Calcitonin Gene-Related Peptide (CGRP) Antagonists, Other Drug Classes
3) Route of Administration: Oral, Sublingual, Other Routes
4) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) Application Area: Hospitals, Mental Healthcare Centers, Other Applications
Further breakdowns within these segments include:
- CBT subtypes such as Exposure Therapy, Dialectical Behavior Therapy (DBT), Acceptance and Commitment Therapy (ACT), Mindfulness-Based Cognitive Therapy (MBCT), and Rational Emotive Behavior Therapy (REBT)
- Medication categories including Beta Blockers, Buspirone, Anticonvulsants, Atypical Antipsychotics, and Herbal and Natural Supplements
- Other treatment options covering Telepsychiatry, Biofeedback and Neurofeedback, Virtual Reality Therapy, Mobile Health Applications, and Support Groups and Counseling Services
This detailed segmentation helps in understanding the diverse treatment pathways and delivery methods that are shaping the future landscape of panic attack treatments.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Panic Attack Treatment Market here
News-ID: 4483261 • Views: …
More Releases from The Business Research Company
Global Factors Influencing the Rapid Evolution of the Noonan Syndrome Market
The Noonan Syndrome market is attracting considerable attention as advancements in diagnostics and personalized treatments continue to evolve. With ongoing innovations and expanded healthcare services, this market is set for substantial growth in the coming years. Let's explore the market's projected value, key players, emerging trends, and the various segments that define this healthcare sector.
Noonan Syndrome Market Size and Growth Outlook
The Noonan Syndrome market is projected to experience significant…
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Non- …
The non-proliferative diabetic retinopathy market is set to experience significant growth in the coming years, driven by advancements in treatment options and increasing awareness of the condition. As healthcare infrastructure expands and technology improves, the market is positioned for steady progress through 2030. Let's explore the key aspects shaping this evolving industry.
Projected Growth Trajectory of the Non-Proliferative Diabetic Retinopathy Market
The market for non-proliferative diabetic retinopathy is anticipated to reach…
Analysis of Key Market Segments Influencing the Non-Cystic Fibrosis Bronchiectas …
The non-cystic fibrosis bronchiectasis market is gaining considerable attention as the need for effective respiratory disease management grows. With advancements in medical technology and expanding healthcare access, this market is set to experience significant progress in the coming years. Below, we explore the market size projections, leading companies, key growth factors, and detailed segmentation shaping this evolving industry.
Projected Market Size and Growth of the Non-Cystic Fibrosis Bronchiectasis Market
The market…
Top Players and Competitive Dynamics in the Night Blindness Treatment Market
The night blindness treatment market is on track for substantial growth over the coming years, fueled by advancements in medical technology and rising awareness of eye health. As the demand for innovative therapies and improved care options grows, this sector is expected to expand significantly by the end of the decade. Below is a detailed look at the market size, key players, driving factors, emerging trends, and segmentation shaping the…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
